{"entity":{"type":"insider","cik":"0001768161","url":"/insider/0001768161","json_url":"/insider/0001768161.json","name":"Globeways Holdings II Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":6,"first":"2019-02-21","last":"2019-12-20","span_basis":"filed_date"},"name_variants":[{"name":"Globeways Holdings II Ltd","source":"filing","n_filings":6,"first_seen":"2019-02-21","last_seen":"2019-12-20"}],"transactions":[{"id":8725355,"accession":"0000899243-19-029791","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-029791","line_url":"/filing/0000899243-19-029791#line-4","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 - TPO Investments LLC; F2 Capital I 2019, LLC; F2 BBG LLC; Jovan-Embiricos Morana; F2 MG Ltd; Globeways Holdings II Ltd; F2 Capital I 2015 Ltd; Globeways Holdings Ltd; F2 Captial I 2017 Ltd; F2 Bioscience II 2017 Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35323.0,"shares_display":"35,323","price_per_share":16.4714,"price_display":"16.47","price_state":"stated","total_value":581819.2622,"total_display":"581,819.26","shares_owned_after":155986.0,"shares_owned_after_display":"155,986","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-19","filed_date":"2019-12-20","scope":"insider"},{"id":8725352,"accession":"0000899243-19-029791","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-029791","line_url":"/filing/0000899243-19-029791#line-3","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 - TPO Investments LLC; F2 Capital I 2019, LLC; F2 BBG LLC; Jovan-Embiricos Morana; F2 MG Ltd; Globeways Holdings II Ltd; F2 Capital I 2015 Ltd; Globeways Holdings Ltd; F2 Captial I 2017 Ltd; F2 Bioscience II 2017 Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6642.0,"shares_display":"6,642","price_per_share":16.4714,"price_display":"16.47","price_state":"stated","total_value":109403.0388,"total_display":"109,403.04","shares_owned_after":82575.0,"shares_owned_after_display":"82,575","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-19","filed_date":"2019-12-20","scope":"insider"},{"id":8725350,"accession":"0000899243-19-029791","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-029791","line_url":"/filing/0000899243-19-029791#line-2","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 - TPO Investments LLC; F2 Capital I 2019, LLC; F2 BBG LLC; Jovan-Embiricos Morana; F2 MG Ltd; Globeways Holdings II Ltd; F2 Capital I 2015 Ltd; Globeways Holdings Ltd; F2 Captial I 2017 Ltd; F2 Bioscience II 2017 Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2433.0,"shares_display":"2,433","price_per_share":17.006,"price_display":"17.01","price_state":"stated","total_value":41375.598,"total_display":"41,375.60","shares_owned_after":191309.0,"shares_owned_after_display":"191,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-20","scope":"insider"},{"id":8725348,"accession":"0000899243-19-029791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-029791","line_url":"/filing/0000899243-19-029791#line-1","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 - TPO Investments LLC; F2 Capital I 2019, LLC; F2 BBG LLC; Jovan-Embiricos Morana; F2 MG Ltd; Globeways Holdings II Ltd; F2 Capital I 2015 Ltd; Globeways Holdings Ltd; F2 Captial I 2017 Ltd; F2 Bioscience II 2017 Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":458.0,"shares_display":"458","price_per_share":17.006,"price_display":"17.01","price_state":"stated","total_value":7788.748,"total_display":"7,788.75","shares_owned_after":89217.0,"shares_owned_after_display":"89,217","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-20","scope":"insider"},{"id":7886918,"accession":"0000899243-19-028968","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968#line-12","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4153.0,"shares_display":"4,153","price_per_share":17.6525,"price_display":"17.65","price_state":"stated","total_value":73310.8325,"total_display":"73,310.83","shares_owned_after":1299876.0,"shares_owned_after_display":"1,299,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-11","scope":"insider"},{"id":7886914,"accession":"0000899243-19-028968","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968#line-11","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1381.0,"shares_display":"1,381","price_per_share":17.6525,"price_display":"17.65","price_state":"stated","total_value":24378.1025,"total_display":"24,378.10","shares_owned_after":432319.0,"shares_owned_after_display":"432,319","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-11","scope":"insider"},{"id":7886910,"accession":"0000899243-19-028968","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968#line-10","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1155.0,"shares_display":"1,155","price_per_share":17.6525,"price_display":"17.65","price_state":"stated","total_value":20388.6375,"total_display":"20,388.64","shares_owned_after":361665.0,"shares_owned_after_display":"361,665","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-11","scope":"insider"},{"id":7886906,"accession":"0000899243-19-028968","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968#line-9","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1054.0,"shares_display":"1,054","price_per_share":17.6525,"price_display":"17.65","price_state":"stated","total_value":18605.735,"total_display":"18,605.74","shares_owned_after":330238.0,"shares_owned_after_display":"330,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-11","scope":"insider"},{"id":7886902,"accession":"0000899243-19-028968","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968#line-8","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30475.0,"shares_display":"30,475","price_per_share":17.6232,"price_display":"17.62","price_state":"stated","total_value":537067.02,"total_display":"537,067.02","shares_owned_after":1304029.0,"shares_owned_after_display":"1,304,029","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider"},{"id":7886898,"accession":"0000899243-19-028968","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968#line-7","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10135.0,"shares_display":"10,135","price_per_share":17.6232,"price_display":"17.62","price_state":"stated","total_value":178611.132,"total_display":"178,611.13","shares_owned_after":433700.0,"shares_owned_after_display":"433,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider"},{"id":7886896,"accession":"0000899243-19-028968","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968#line-6","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8479.0,"shares_display":"8,479","price_per_share":17.6232,"price_display":"17.62","price_state":"stated","total_value":149427.1128,"total_display":"149,427.11","shares_owned_after":362820.0,"shares_owned_after_display":"362,820","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider"},{"id":7886893,"accession":"0000899243-19-028968","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968#line-5","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7741.0,"shares_display":"7,741","price_per_share":17.6232,"price_display":"17.62","price_state":"stated","total_value":136421.1912,"total_display":"136,421.19","shares_owned_after":331292.0,"shares_owned_after_display":"331,292","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider"},{"id":7886888,"accession":"0000899243-19-028968","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968#line-4","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75067.0,"shares_display":"75,067","price_per_share":17.6511,"price_display":"17.65","price_state":"stated","total_value":1325015.1237,"total_display":"1,325,015.12","shares_owned_after":1334504.0,"shares_owned_after_display":"1,334,504","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":7886885,"accession":"0000899243-19-028968","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968#line-3","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24966.0,"shares_display":"24,966","price_per_share":17.6511,"price_display":"17.65","price_state":"stated","total_value":440677.3626,"total_display":"440,677.36","shares_owned_after":443835.0,"shares_owned_after_display":"443,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":7886883,"accession":"0000899243-19-028968","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968#line-2","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20886.0,"shares_display":"20,886","price_per_share":17.6511,"price_display":"17.65","price_state":"stated","total_value":368660.8746,"total_display":"368,660.87","shares_owned_after":371299.0,"shares_owned_after_display":"371,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":7886879,"accession":"0000899243-19-028968","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-028968","line_url":"/filing/0000899243-19-028968#line-1","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings Ltd; F2 MG Ltd; Jovan-Embiricos Morana; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings II Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19070.0,"shares_display":"19,070","price_per_share":17.6511,"price_display":"17.65","price_state":"stated","total_value":336606.477,"total_display":"336,606.48","shares_owned_after":339033.0,"shares_owned_after_display":"339,033","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":8580892,"accession":"0000899243-19-025909","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-025909","line_url":"/filing/0000899243-19-025909#line-4","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 MG Ltd; Jovan-Embiricos Morana; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings Ltd; Globeways Holdings II Ltd; F2 - TPO Investments LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2085.0,"shares_display":"2,085","price_per_share":15.1571,"price_display":"15.16","price_state":"stated","total_value":31602.5535,"total_display":"31,602.55","shares_owned_after":1409571.0,"shares_owned_after_display":"1,409,571","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-22","filed_date":"2019-10-24","scope":"insider"},{"id":8580891,"accession":"0000899243-19-025909","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-025909","line_url":"/filing/0000899243-19-025909#line-3","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 MG Ltd; Jovan-Embiricos Morana; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings Ltd; Globeways Holdings II Ltd; F2 - TPO Investments LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":693.0,"shares_display":"693","price_per_share":15.1571,"price_display":"15.16","price_state":"stated","total_value":10503.8703,"total_display":"10,503.87","shares_owned_after":392185.0,"shares_owned_after_display":"392,185","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-22","filed_date":"2019-10-24","scope":"insider"},{"id":8580890,"accession":"0000899243-19-025909","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-025909","line_url":"/filing/0000899243-19-025909#line-2","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 MG Ltd; Jovan-Embiricos Morana; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings Ltd; Globeways Holdings II Ltd; F2 - TPO Investments LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":580.0,"shares_display":"580","price_per_share":15.1571,"price_display":"15.16","price_state":"stated","total_value":8791.118,"total_display":"8,791.12","shares_owned_after":392185.0,"shares_owned_after_display":"392,185","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-22","filed_date":"2019-10-24","scope":"insider"},{"id":8580889,"accession":"0000899243-19-025909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-025909","line_url":"/filing/0000899243-19-025909#line-1","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 MG Ltd; Jovan-Embiricos Morana; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Globeways Holdings Ltd; Globeways Holdings II Ltd; F2 - TPO Investments LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":530.0,"shares_display":"530","price_per_share":15.1571,"price_display":"15.16","price_state":"stated","total_value":8033.263,"total_display":"8,033.26","shares_owned_after":358103.0,"shares_owned_after_display":"358,103","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-22","filed_date":"2019-10-24","scope":"insider"},{"id":8197830,"accession":"0000899243-19-024208","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-12","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5516.0,"shares_display":"5,516","price_per_share":17.3114,"price_display":"17.31","price_state":"stated","total_value":95489.6824,"total_display":"95,489.68","shares_owned_after":1411656.0,"shares_owned_after_display":"1,411,656","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-24","scope":"insider"},{"id":8197826,"accession":"0000899243-19-024208","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-11","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1835.0,"shares_display":"1,835","price_per_share":17.3114,"price_display":"17.31","price_state":"stated","total_value":31766.419,"total_display":"31,766.42","shares_owned_after":469464.0,"shares_owned_after_display":"469,464","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-24","scope":"insider"},{"id":8197822,"accession":"0000899243-19-024208","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-10","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1535.0,"shares_display":"1,535","price_per_share":17.3114,"price_display":"17.31","price_state":"stated","total_value":26572.999,"total_display":"26,573.00","shares_owned_after":392765.0,"shares_owned_after_display":"392,765","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-24","scope":"insider"},{"id":8197819,"accession":"0000899243-19-024208","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-9","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1401.0,"shares_display":"1,401","price_per_share":17.3114,"price_display":"17.31","price_state":"stated","total_value":24253.2714,"total_display":"24,253.27","shares_owned_after":358633.0,"shares_owned_after_display":"358,633","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-24","scope":"insider"},{"id":8197814,"accession":"0000899243-19-024208","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-8","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":683.0,"shares_display":"683","price_per_share":17.3114,"price_display":"17.31","price_state":"stated","total_value":11823.6862,"total_display":"11,823.69","shares_owned_after":174871.0,"shares_owned_after_display":"174,871","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-24","scope":"insider"},{"id":8197809,"accession":"0000899243-19-024208","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-7","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":351.0,"shares_display":"351","price_per_share":17.3114,"price_display":"17.31","price_state":"stated","total_value":6076.3014,"total_display":"6,076.30","shares_owned_after":89675.0,"shares_owned_after_display":"89,675","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-24","scope":"insider"},{"id":8197804,"accession":"0000899243-19-024208","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-6","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":197343.0,"shares_display":"197,343","price_per_share":17.9354,"price_display":"17.94","price_state":"stated","total_value":3539425.6422,"total_display":"3,539,425.64","shares_owned_after":1417172.0,"shares_owned_after_display":"1,417,172","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-20","filed_date":"2019-09-24","scope":"insider"},{"id":8197801,"accession":"0000899243-19-024208","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-5","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65633.0,"shares_display":"65,633","price_per_share":17.9354,"price_display":"17.94","price_state":"stated","total_value":1177154.1082,"total_display":"1,177,154.11","shares_owned_after":471299.0,"shares_owned_after_display":"471,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-20","filed_date":"2019-09-24","scope":"insider"},{"id":8197797,"accession":"0000899243-19-024208","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-4","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54907.0,"shares_display":"54,907","price_per_share":17.9354,"price_display":"17.94","price_state":"stated","total_value":984779.0078,"total_display":"984,779.01","shares_owned_after":394300.0,"shares_owned_after_display":"394,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-20","filed_date":"2019-09-24","scope":"insider"},{"id":8197794,"accession":"0000899243-19-024208","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-3","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50134.0,"shares_display":"50,134","price_per_share":17.9354,"price_display":"17.94","price_state":"stated","total_value":899173.3436,"total_display":"899,173.34","shares_owned_after":360034.0,"shares_owned_after_display":"360,034","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-20","filed_date":"2019-09-24","scope":"insider"},{"id":8197792,"accession":"0000899243-19-024208","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-2","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24446.0,"shares_display":"24,446","price_per_share":17.9354,"price_display":"17.94","price_state":"stated","total_value":438448.7884,"total_display":"438,448.79","shares_owned_after":175554.0,"shares_owned_after_display":"175,554","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-20","filed_date":"2019-09-24","scope":"insider"},{"id":8197788,"accession":"0000899243-19-024208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-024208","line_url":"/filing/0000899243-19-024208#line-1","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 MG Ltd; Globeways Holdings Ltd; F2 Capital I 2019, LLC; F2 - TPO Investments LLC; F2 Capital I 2015 Ltd; F2 Captial I 2017 Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12537.0,"shares_display":"12,537","price_per_share":17.9354,"price_display":"17.94","price_state":"stated","total_value":224856.1098,"total_display":"224,856.11","shares_owned_after":90026.0,"shares_owned_after_display":"90,026","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-20","filed_date":"2019-09-24","scope":"insider"},{"id":8345964,"accession":"0000899243-19-022834","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-19-022834","line_url":"/filing/0000899243-19-022834#line-9","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; Jovan-Embiricos Morana; F2 Capital I 2019, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12214.0,"shares_display":"12,214","price_per_share":17.5548,"price_display":"17.55","price_state":"stated","total_value":214414.3272,"total_display":"214,414.33","shares_owned_after":102563.0,"shares_owned_after_display":"102,563","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-04","filed_date":"2019-09-05","scope":"insider"},{"id":8345959,"accession":"0000899243-19-022834","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-19-022834","line_url":"/filing/0000899243-19-022834#line-8","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; Jovan-Embiricos Morana; F2 Capital I 2019, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10559.0,"shares_display":"10,559","price_per_share":17.0142,"price_display":"17.01","price_state":"stated","total_value":179652.9378,"total_display":"179,652.94","shares_owned_after":114777.0,"shares_owned_after_display":"114,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8345955,"accession":"0000899243-19-022834","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-19-022834","line_url":"/filing/0000899243-19-022834#line-7","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; Jovan-Embiricos Morana; F2 Capital I 2019, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":17.0068,"price_display":"17.01","price_state":"stated","total_value":62925.16,"total_display":"62,925.16","shares_owned_after":125336.0,"shares_owned_after_display":"125,336","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-29","filed_date":"2019-09-05","scope":"insider"},{"id":8345951,"accession":"0000899243-19-022834","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-19-022834","line_url":"/filing/0000899243-19-022834#line-6","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; Jovan-Embiricos Morana; F2 Capital I 2019, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6700.0,"shares_display":"6,700","price_per_share":17.0061,"price_display":"17.01","price_state":"stated","total_value":113940.87,"total_display":"113,940.87","shares_owned_after":129036.0,"shares_owned_after_display":"129,036","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-28","filed_date":"2019-09-05","scope":"insider"},{"id":8345946,"accession":"0000899243-19-022834","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-19-022834","line_url":"/filing/0000899243-19-022834#line-5","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; Jovan-Embiricos Morana; F2 Capital I 2019, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":17.0113,"price_display":"17.01","price_state":"stated","total_value":20413.56,"total_display":"20,413.56","shares_owned_after":135736.0,"shares_owned_after_display":"135,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-27","filed_date":"2019-09-05","scope":"insider"},{"id":8345941,"accession":"0000899243-19-022834","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-022834","line_url":"/filing/0000899243-19-022834#line-4","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; Jovan-Embiricos Morana; F2 Capital I 2019, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29128.0,"shares_display":"29,128","price_per_share":17.0104,"price_display":"17.01","price_state":"stated","total_value":495478.9312,"total_display":"495,478.93","shares_owned_after":136936.0,"shares_owned_after_display":"136,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-26","filed_date":"2019-09-05","scope":"insider"},{"id":8345936,"accession":"0000899243-19-022834","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-022834","line_url":"/filing/0000899243-19-022834#line-3","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; Jovan-Embiricos Morana; F2 Capital I 2019, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3.0,"shares_display":"3","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":51.0,"total_display":"51.00","shares_owned_after":166064.0,"shares_owned_after_display":"166,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-09-05","scope":"insider"},{"id":8345931,"accession":"0000899243-19-022834","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-022834","line_url":"/filing/0000899243-19-022834#line-2","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; Jovan-Embiricos Morana; F2 Capital I 2019, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":17.03,"price_display":"17.03","price_state":"stated","total_value":1703.0,"total_display":"1,703.00","shares_owned_after":166067.0,"shares_owned_after_display":"166,067","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-22","filed_date":"2019-09-05","scope":"insider"},{"id":8345920,"accession":"0000899243-19-022834","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-022834","line_url":"/filing/0000899243-19-022834#line-1","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; Jovan-Embiricos Morana; F2 Capital I 2019, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":8500.0,"total_display":"8,500.00","shares_owned_after":166167.0,"shares_owned_after_display":"166,167","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-21","filed_date":"2019-09-05","scope":"insider"},{"id":8502390,"accession":"0000899243-19-004404","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-19-004404","line_url":"/filing/0000899243-19-004404#line-9","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 Bioscience II 2017 Ltd; F2 - TPO Investments LLC; F2 Capital I 2019, LLC; Globeways Holdings Ltd; F2 Captial I 2017 Ltd; F2 Capital I 2015 Ltd; F2 MG Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","shares_owned_after":200000.0,"shares_owned_after_display":"200,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-21","scope":"insider"},{"id":8502385,"accession":"0000899243-19-004404","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-19-004404","line_url":"/filing/0000899243-19-004404#line-8","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 Bioscience II 2017 Ltd; F2 - TPO Investments LLC; F2 Capital I 2019, LLC; Globeways Holdings Ltd; F2 Captial I 2017 Ltd; F2 Capital I 2015 Ltd; F2 MG Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":166667.0,"shares_display":"166,667","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":2500005.0,"total_display":"2,500,005.00","shares_owned_after":449207.0,"shares_owned_after_display":"449,207","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-21","scope":"insider"},{"id":8502381,"accession":"0000899243-19-004404","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-19-004404","line_url":"/filing/0000899243-19-004404#line-7","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 Bioscience II 2017 Ltd; F2 - TPO Investments LLC; F2 Capital I 2019, LLC; Globeways Holdings Ltd; F2 Captial I 2017 Ltd; F2 Capital I 2015 Ltd; F2 MG Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":166667.0,"shares_display":"166,667","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":2500005.0,"total_display":"2,500,005.00","shares_owned_after":166667.0,"shares_owned_after_display":"166,667","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-21","scope":"insider"},{"id":8502376,"accession":"0000899243-19-004404","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-19-004404","line_url":"/filing/0000899243-19-004404#line-6","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"TCR2 THERAPEUTICS INC.","issuer_ticker":"TCRR","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Globeways Holdings II Ltd; F2 BBG LLC; F2 Bioscience II 2017 Ltd; F2 - TPO Investments LLC; F2 Capital I 2019, LLC; Globeways Holdings Ltd; F2 Captial I 2017 Ltd; F2 Capital I 2015 Ltd; F2 MG Ltd; Jovan-Embiricos Morana","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133333.0,"shares_display":"133,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1999995.0,"total_display":"1,999,995.00","shares_owned_after":536962.0,"shares_owned_after_display":"536,962","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001750019","name":"TCR2 THERAPEUTICS INC.","url":"/issuer/0001750019","role":"Ten percent owner","n_filings":6,"first_seen":"2019-02-21","last_seen":"2019-12-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001768161","retrieved_at":"2026-08-21T15:32:27+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}